{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,20]],"date-time":"2026-06-20T16:01:34Z","timestamp":1781971294329,"version":"3.54.5"},"reference-count":28,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2006,6,1]],"date-time":"2006-06-01T00:00:00Z","timestamp":1149120000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Progress in Neuro-Psychopharmacology and Biological Psychiatry"],"published-print":{"date-parts":[[2006,6]]},"DOI":"10.1016\/j.pnpbp.2005.11.037","type":"journal-article","created":{"date-parts":[[2006,2,8]],"date-time":"2006-02-08T13:25:05Z","timestamp":1139405105000},"page":"658-662","source":"Crossref","is-referenced-by-count":39,"title":["The relationship between prolactin response and clinical efficacy of risperidone in acute psychotic inpatients"],"prefix":"10.1016","volume":"30","author":[{"given":"Bun-Hee","family":"Lee","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong-Ku","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.pnpbp.2005.11.037_bib1","series-title":"The diagnostic and statistical manual of mental disorders","author":"American Psychiatric Association","year":"1994"},{"key":"10.1016\/j.pnpbp.2005.11.037_bib2","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1210\/jcem-37-6-977","article-title":"Estrogen potentiation of phenothazine-induced prolactin secretion in man","volume":"37","author":"Buckman","year":"1973","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.pnpbp.2005.11.037_bib3","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/S0165-1781(98)00085-7","article-title":"Change in plasma prolactin and clinical response to haloperidol in schizophrenia and schizoaffective disorder","volume":"81","author":"Chou","year":"1998","journal-title":"Psychiatr Res"},{"key":"10.1016\/j.pnpbp.2005.11.037_bib4","series-title":"Textbook of Gynecology","first-page":"447","article-title":"Disorders of prolactin secretion","author":"Corenblum","year":"1993"},{"key":"10.1016\/j.pnpbp.2005.11.037_bib5","doi-asserted-by":"crossref","first-page":"113S","DOI":"10.1016\/S0006-3223(98)90824-1","article-title":"Relationship between D2 occupancy and prolactin levels in first episode psychosis","volume":"43","author":"Daskalakis","year":"1998","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.pnpbp.2005.11.037_bib6","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1016\/S0149-2918(00)80086-7","article-title":"The effects of olanzapine, risperidone, and haloperidol on plasma prolactin levels in patients with schizophrenia","volume":"9","author":"David","year":"2000","journal-title":"Clin Ther"},{"key":"10.1016\/j.pnpbp.2005.11.037_bib7","doi-asserted-by":"crossref","first-page":"S75","DOI":"10.1016\/S0920-9964(98)00159-5","article-title":"Neuroleptic-induced hyperprolactinemia","volume":"35","author":"Dickson","year":"1999","journal-title":"Schizophr Res"},{"key":"10.1016\/j.pnpbp.2005.11.037_bib8","doi-asserted-by":"crossref","first-page":"2291","DOI":"10.2165\/00003495-200464200-00003","article-title":"Antipsychotic-induced hyperprolactinemia: mechanism, clinical features and management","volume":"64","author":"Haddad","year":"2004","journal-title":"Drugs"},{"key":"10.1016\/j.pnpbp.2005.11.037_bib9","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1016\/S0028-3908(96)00100-1","article-title":"Dopamine receptors and brain function","volume":"35","author":"Jaber","year":"1996","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.pnpbp.2005.11.037_bib10","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1176\/appi.ajp.157.4.514","article-title":"Relationship between dopamine D2 occupancy, clinical response and side effects: a double-blind PET study of first-episode schizophrenia","volume":"157","author":"Kapur","year":"2000","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.pnpbp.2005.11.037_bib11","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1124\/jpet.102.035303","article-title":"The differential effects of atypical antipsychotics on prolactin elevation are explained by their differential blood\u2013brain disposition: a pharmacological analysis in rats","volume":"302","author":"Kapur","year":"2002","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.pnpbp.2005.11.037_bib12","doi-asserted-by":"crossref","first-page":"425","DOI":"10.4158\/EP.6.6.425","article-title":"Risperidone-associated hyperprolactinemia","volume":"6","author":"Kearns","year":"2000","journal-title":"Endocr Pract"},{"key":"10.1016\/j.pnpbp.2005.11.037_bib13","doi-asserted-by":"crossref","first-page":"315","DOI":"10.4088\/JCP.v60n0509","article-title":"Risperidone and associated amenorrhea: a report of 5 cases","volume":"60","author":"Kim","year":"1999","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.pnpbp.2005.11.037_bib14","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/S0306-4530(02)00127-0","article-title":"Prevalence of hyperprolactinemia in schizophrenic patients treated with conventional antipsychotic medications or risperidone","volume":"28","author":"Kinon","year":"2003","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.pnpbp.2005.11.037_bib15","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1097\/00004714-199902000-00011","article-title":"Prolactin levels and adverse events in patients treated with risperidone","volume":"19","author":"Kleinberg","year":"1999","journal-title":"J Clin Psychopharmacol"},{"key":"10.1016\/j.pnpbp.2005.11.037_bib16","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1080\/13651500510014747","article-title":"Treatment in risperidone-induced amenorrhea","volume":"9","author":"Lee","year":"2005","journal-title":"Int J Psychiatry Clin Pract"},{"key":"10.1016\/j.pnpbp.2005.11.037_bib17","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1001\/archpsyc.1994.03950100009002","article-title":"Effects of the menstrual cycle on dependent variables in mood disorder research","volume":"51","author":"Leibenluft","year":"1994","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.pnpbp.2005.11.037_bib18","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1007\/s004060170049","article-title":"Neuroendocrine responsivities of the pituitary dopamine system in male schizophrenic patients during treatment with clozapine, olanzapine, sulpride or haloperidol","volume":"251","author":"Markianos","year":"2001","journal-title":"Eur Arch Psychiatry Clin Neurosci"},{"key":"10.1016\/j.pnpbp.2005.11.037_bib19","series-title":"The pituitary","first-page":"149","author":"Melemd","year":"1995"},{"key":"10.1016\/j.pnpbp.2005.11.037_bib20","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/0165-1781(83)90001-X","article-title":"Serum neuroleptic and prolactin levels in schizophrenic patients and clinical response","volume":"9","author":"Meltzer","year":"1983","journal-title":"Psychiatr Res"},{"key":"10.1016\/j.pnpbp.2005.11.037_bib21","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1002\/ajmg.1303","article-title":"Relationship between Taq1 A dopamine D2 receptor (DRD2) polymorphism and prolactin response to bromperidol","volume":"105","author":"Mihara","year":"2001","journal-title":"Am J Med Genet"},{"key":"10.1016\/j.pnpbp.2005.11.037_bib23","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1002\/(SICI)1099-1077(199711\/12)12:6<591::AID-HUP926>3.0.CO;2-U","article-title":"Prolactin response to nemonapride, a new antipsychotic drug, in schizophrenic patients","volume":"12","author":"Otani","year":"1997","journal-title":"Hum Psychopharmacol"},{"key":"10.1016\/j.pnpbp.2005.11.037_bib24","doi-asserted-by":"crossref","first-page":"799","DOI":"10.2466\/pr0.1962.10.3.799","article-title":"The Brief Psychotic Rating Scale","volume":"10","author":"Overall","year":"1962","journal-title":"Psychol Rep"},{"key":"10.1016\/j.pnpbp.2005.11.037_bib22","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1097\/00004714-200204000-00002","article-title":"The effects of antipsychotic-induced hyperprolactinaemia on the hypothalamic-pituitary-gonadal axis","volume":"22","author":"Smith","year":"2002","journal-title":"J Clin Psychopharmacol"},{"key":"10.1016\/j.pnpbp.2005.11.037_bib25","first-page":"357","article-title":"Serum prolactin as a correlate of clinical responses to haloperidol","volume":"11","author":"Van Putten","year":"1991","journal-title":"J Clin Psychopharmacol"},{"key":"10.1016\/j.pnpbp.2005.11.037_bib26","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1210\/jc.81.4.1483","article-title":"Gender differences in the temporal organization of prolactin (PRL) secretion: evidence for a sleep-independent circadian rhythm of circulating PRL levels\u2014a clinical research center study","volume":"81","author":"Waldstreicher","year":"1996","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.pnpbp.2005.11.037_bib27","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1192\/bjp.185.2.147","article-title":"Prolactin levels in antipsychotic treatment of patients with schizophrenia carrying the DRD2\u204eA1 allele","volume":"185","author":"Young","year":"2004","journal-title":"Br J Psychiatry"},{"key":"10.1016\/j.pnpbp.2005.11.037_bib28","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/S0165-1781(02)00022-7","article-title":"Risperidone-induced increase in serum prolactin is correlated with positive symptom improvement in chronic schizophrenia","volume":"109","author":"Zhang","year":"2002","journal-title":"Psychiatr Res"}],"container-title":["Progress in Neuro-Psychopharmacology and Biological Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0278584605003933?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0278584605003933?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,1,18]],"date-time":"2019-01-18T10:54:53Z","timestamp":1547808893000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0278584605003933"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,6]]},"references-count":28,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2006,6]]}},"alternative-id":["S0278584605003933"],"URL":"https:\/\/doi.org\/10.1016\/j.pnpbp.2005.11.037","relation":{},"ISSN":["0278-5846"],"issn-type":[{"value":"0278-5846","type":"print"}],"subject":[],"published":{"date-parts":[[2006,6]]}}}